Prelude Therapeutics, Inc. (PRLD)
4.33
-0.17
(-3.78%)
USD |
NASDAQ |
May 21, 16:00
4.63
+0.30
(+6.93%)
After-Hours: 19:59
Prelude Therapeutics Total Assets (Quarterly) : 119.64M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 673.70M |
| Sana Biotechnology, Inc. | 373.59M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Agenus, Inc. | 186.46M |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 59.46M |
| Shareholders Equity (Quarterly) | 60.18M |
| Debt to Equity Ratio | 0.2945 |
| Current Ratio | 2.028 |
| Net Debt Paydown Yield | 0.03% |